Navigation Links
Inimex Announces Appointment of New CEO
Date:11/23/2009

BURNABY, BC, Nov. 23 /PRNewswire/ - Inimex Pharmaceuticals, Inc. announced today that it has appointed Michael J. Abrams, Ph.D as its President and CEO.

Abrams brings more than 25 years of drug discovery and development experience to Inimex. He is a co-inventor of the nuclear medicine imaging agent, Cardiolite, and worked from 1984 to 1996 at Johnson Matthey, plc where he was Manager, Biomedical Research Worldwide. In 1996, Abrams led the establishment of AnorMED in Langley, BC and was President and CEO from 1996 to 2006. AnorMED discovered and developed Mozobil, a drug for improving stem cell collection in cancer patients undergoing stem cell transplantation. AnorMED was acquired by Genzyme Corp. for $580M in 2006, and Mozobil was FDA approved in December 2008. Abrams is actively involved in the Vancouver biotech community as a member of public, private and not-for-profit boards.

"We are thrilled that Dr. Abrams has joined the Inimex executive team," said Robert Fildes, Chairman of the Board of Inimex. "His experience and leadership qualities will be a great asset to Inimex as the company makes the transition from a pre-clinical company to one with a drug candidate advancing through clinical development."

Dr. John R. North, who led the early development of Inimex' drug technology, serving as EVP of R&D in 2004 and then President and Chief Executive Officer from 2005 to 2009, will assume a new role as Chief Operating Officer.

"In this era of increasing antibiotic resistance and emerging infectious diseases, new strategies for dealing with these problems are very much in demand. Inimex, with its Innate Defense Regulator technology, is in a great position to address these needs," said Abrams.

    About Inimex Pharmaceuticals
    ----------------------------

Inimex Pharmaceuticals Inc. is a privately held biopharmaceutical company dedicated to the discovery and development of new m
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 ­ RedBrick Health , ... change technology, today announces that EmblemHealth , the ... wellness company, is now providing the RedBrick Compass health ... program, to all of its members. EmblemHealth is among ... these interlocking components of the RedBrick 5 advanced product ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 More than ... and about 1 in 3 seniors will die with ... ). These jaw-dropping figures have shocked many Americans into ... hopefully, help prevent these tragic age-related cognitive disorders. Jonathan ... life’s work to help others achieve true cognitive enhancement. ...
(Date:1/15/2014)... January 15, 2014 DTS Language ... to its Online Web Portal for Life Science organizations ... the ability to specify the subject matter of their ... life science sub-domains. This will help reduce time-to-delivery of ... fields, and decrease the likelihood of error. , “All ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of ... treatment of tinnitus. Patients listen to sound therapy ... over a period of weeks to months, their tinnitus ... Therapy in two forms: Notched Music and Notched White ... of a new form of Tailor-Made Notched Sound Therapy: ...
Breaking Biology Technology:EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2DTS Improves Efficiency for Life Science Document Translations 2
... Dr. William Yasnoff agreed that $30 million is ... the adoption of electronic health records, but not too small ... idea. , ,Yasnoff, founder of the eHealth Trust Initiative, continues ... or bank, for all electronic health records. He views a ...
... and we have to do something major about its inefficiencies. ... (27 percent), industry (25 percent), and buildings (48 percent). The ... statistics published in 2003. , ,I was told ... also said the only way for the United States to ...
... using technology efficiently? Protecting customer information? Upgrading major ... inside your business so that you know that ... in mind? , ,Businesses are becoming increasingly dependent ... manage risks, or even just to operate. But ...
Cached Biology Technology:Yasnoff: Wisconsin should invest in health record bank 2Yasnoff: Wisconsin should invest in health record bank 3Energy conservation might take us farther than renewable fuels 2Energy conservation might take us farther than renewable fuels 3Energy conservation might take us farther than renewable fuels 4Energy conservation might take us farther than renewable fuels 5Energy conservation might take us farther than renewable fuels 6Are your business and technology goals aligned? 2Are your business and technology goals aligned? 3
(Date:4/15/2014)... dental researchers have found a less invasive way ... mouth to study how the mouth,s natural defenses ... some specialized immune cells (white blood cells known ... in the mouthor reject foreign tissues, such as ... about treating and preventing such health issues as ...
(Date:4/15/2014)... Academy of Arts and Sciences (KNAW) has announced the ... awarded prestigious Heineken Prizes (one million US dollars prize ... for their great merits to science. , This year ... awarded to the Austrian-American chemist Erwin Chargaff in 1964. ... Prizes to the following laureates: , Christopher ...
(Date:4/15/2014)... parasites of cuttlefish, squid and octopus has uncovered ... shown how they may help in investigating populations ... has described 10 new parasite species− dicyemid mesozoans ... (cuttlefish, squid and octopus). They are the ... Australian waters. , "Although dicyemid parasites have ...
Breaking Biology News(10 mins):New method isolates immune cells for researchers to study how they ward off oral diseases 2Five scientists awarded prestigious Heineken Prizes 2Bizarre parasite may provide cuttlefish clues 2
... LAKE CITY, May 4, 2009 Women who have babies ... than other women. Now, a new study shows their brothers ... the same genes prolong lifespan and female fertility, and may ... women in your family give birth at older ages, you ...
... Health have identified a gene associated with narcolepsy, a ... bouts of sleep that can strike at any time, ... known role in the immune system, which strongly suggests ... the body,s own tissues, plays an important role in ...
... be more vulnerable than men to the cancer-causing effects ... week at the European Multidisciplinary Conference in Thoracic Oncology ... lung cancer patients who were referred to a cancer ... found women tended to be younger when they developed ...
Cached Biology News:Late motherhood boosts family lifespan 2Late motherhood boosts family lifespan 3Late motherhood boosts family lifespan 4Late motherhood boosts family lifespan 5Genetic study confirms the immune system's role in narcolepsy 2Genetic study confirms the immune system's role in narcolepsy 3
... The Zero Background Cloning Kit includes ... selection in E. coli. The pZErO-1 vector ... The small size of the Zeocin resistance ... increased ligation and transformation efficiencies. The kit ...
Polyethylene Glycol 8000, 1 kg. PEG 8000.Used in differential DNA precipitation. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Panomer 9 oligodeoxynucleotides are random primers that are labeled at the 5' end with our proprietary QSY 7 dye and they are useful for assessing microarray spot morphology, hybridization potential ...
Alkaline Phosphatase Stabilizer Solution, 1 L...
Biology Products: